Searchable abstracts of presentations at key conferences in endocrinology

ea0045p34 | Diabetes | BSPED2016

Continuous Subcutaneous Insulin Infusion results in better glycaemic control and reduced insulin requirements in CFRD: Report of 2 cases in children

Trewella E F , Spowart K , Nambisan A Kesavath Raman , Nolan SE , Carr S , Balfour-Lynn I M , Alexander Saji , Bridges Nicola

Introduction: Continuous Subcutaneous Insulin Infusion (CSII) has several advantages over Multiple Daily Injections (MDI) including better hourly delivery and avoidance of injections. However usage of CSII is significantly less in Cystic Fibrosis Related Diabetes (CFRD) compared to type 1 diabetes and published literature on use of CSII in children and adolescents with CFRD is minimal.We report two cases where CSII was used in CFRD resulting in a lower T...